Genasys Inc. Reports Fiscal Third Quarter 2025 Financial Results
Instrumentation and Software for 1st Dam Accepted in
Richard S. Danforth, Chief Executive Officer of Genasys, Inc., commented, “As expected, business in the second half of fiscal 2025 has accelerated dramatically. Just this morning, we finally received confirmation that the remaining deposit on the third group of dams is being transferred today. Across
Continuing, Mr. Danforth said, “While the hardware business has seen diverse and continuing improvement in bookings throughout the year, the software business has been materially constrained by the temporary freezing and uncertainty of federal grant money being made available to state and local initiatives. In fact, more than
Fiscal 3Q 2025 Financial Summary
-
Revenue of
, versus$9.9 million in 3Q 2024$7.2 million -
GAAP operating loss of
( , versus$5.9) million ( in 3Q 2024.$5.4) million -
GAAP net loss of
( versus$6.5) million ( in 3Q 2024.$6.7) million -
GAAP net loss per share (
), versus ($0.14 ) in 3Q 2024.$0.15 -
Adjusted EBITDA of
( , versus$4.8) million ( in 3Q 2024.$4.3) million
Business Highlights
- Received acceptance from Puerto Rico Electric Power Authority (PREPA) for the installation of instrumentation on the first dam and the activation of the software system to be utilized across the Early Warning System (EWS).
-
Executed cost reduction actions expected to reduce operating expenses by
annually, beginning 1Q 2026.$2.5 million - Named Cassandra Monteon interim Chief Financial Officer
-
Generated
in revenues from Puerto Rico EWS project in fiscal 3Q 2025$4.3 million
Business Outlook
Genasys is well underway with the implementation of the Puerto Rico EWS project. In the third fiscal quarter, the Company recorded
Excluding the efforts in
Software bookings continued to be soft in the fiscal third quarter. While numerous federal funding sources have officially been restarted, the increased scrutiny and ongoing uncertainty has impacted customers throughout the nation all the way up from local to state, and even federal agencies. Our Software pipeline continues to expand across all our product offerings, and we continue to expect deal conversions to improve and accelerate as access to federal funds normalizes. In the interim, however, Genasys has taken actions to reduce operating expenses associated with our software business. Beginning in the first fiscal quarter of 2026, we believe those combined actions will deliver approximately
Operating expenses in the third fiscal quarter were down
While the
Fiscal 3Q 2025 Financial Review
Fiscal third quarter revenue was
Gross profit margin was
Operating expenses of
GAAP net loss in the quarter was
Excluding other income and expense, net income tax expense (benefit), depreciation, stock-based compensation and amortization of intangibles, Adjusted EBITDA was
Cash, cash equivalents and marketable securities totaled
We include in this press release the non-GAAP operational metrics of adjusted EBITDA, which we believe provide helpful information to investors with respect to evaluating the Company’s performance. Adjusted EBITDA represents our net loss before other income and expense, net, income tax expense (benefit), depreciation and amortization expense and stock-based compensation. We do not consider these items to be indicative of our core operating performance. The items that are non-cash include depreciation and amortization expense and stock-based compensation. Adjusted EBITDA is a measure used by management to understand and evaluate our core operating performance and trends and to generate future operating plans, make strategic decisions regarding allocation of capital and invest in initiatives that are focused on cultivating new markets for our solutions. In particular, the exclusion of certain expenses in calculating adjusted EBITDA facilitates comparisons of our operating performance on a period-to-period basis.
Webcast and Conference Call Details
Management will host a conference call to discuss the financial results for the third quarter of fiscal year 2025 this afternoon at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. To access the conference call, dial toll-free (888) 390-3967, or international at (862) 298-0702. A webcast will also be available at the following link:
Questions to management may be submitted before the call by emailing them to: [email protected]. A replay of the webcast will be available approximately four hours after the presentation on the investors page of the Company’s website.
About Genasys Inc.
Genasys Inc. (NASDAQ: GNSS) is the global leader in Protective Communications. Incorporating the most comprehensive portfolio of preparedness, response, and analytics software and hardware systems, including the Company’s Long Range Acoustic Device® (LRAD®), the Genasys Protect platform is designed around one premise: ensuring organizations and public safety agencies are Ready when it matters�. Protecting people and saving lives for over 40 years, Genasys covers more than 155 million people in all 50 states and in over 100 countries worldwide. For more information, visit .
Forward-Looking Statements
Except for historical information contained herein, the matters discussed are forward-looking statements within the meaning of the “safe harbor� provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these statements. We base these statements on particular assumptions that we have made in light of our industry experience, the stage of product and market development as well as our perception of historical trends, current market conditions, current economic data, expected future developments and other factors that we believe are appropriate under the circumstances. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in any forward-looking statement. The risks and uncertainties in these forward-looking statements include without limitation the business impact of geopolitical conflicts and other causes that may affect our supply chain, and other risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. Risks and uncertainties are identified and discussed in our filings with the Securities and Exchange Commission. These forward-looking statements are based on information and management’s expectations as of the date hereof. Future results may differ materially from our current expectations. For more information regarding other potential risks and uncertainties, see the “Risk Factors� section of the Company’s Form 10-K for the fiscal year ended September 30, 2024. Genasys Inc. disclaims any intent or obligation to publicly update or revise forward-looking statements, except as otherwise specifically stated.
Genasys Inc. Consolidated Balance Sheets (Unaudited - in thousands) |
||||||
June 30, 2025 |
September 30, 2024 |
|||||
(Unaudited) | ||||||
ASSETS | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ |
5,339 |
$ |
4,945 |
||
Short-term marketable securities |
|
120 |
|
7,945 |
||
Restricted cash |
|
95 |
|
95 |
||
Accounts receivable, net |
|
4,648 |
|
3,283 |
||
Contract assets |
|
2,846 |
|
� |
||
Inventories, net |
|
11,426 |
|
7,313 |
||
Prepaid expenses and other |
|
7,458 |
|
2,559 |
||
Total current assets |
|
31,932 |
|
26,140 |
||
Long-term marketable securities |
|
� |
|
249 |
||
Long-term restricted cash |
|
585 |
|
250 |
||
Property and equipment, net |
|
1,169 |
|
1,291 |
||
Goodwill |
|
13,451 |
|
13,329 |
||
Intangible assets, net |
|
6,724 |
|
8,506 |
||
Operating lease right of use assets, net |
|
2,550 |
|
3,110 |
||
Other assets |
|
982 |
|
1,061 |
||
Total assets | $ |
57,393 |
$ |
53,936 |
||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
Current liabilities: | ||||||
Accounts payable | $ |
7,797 |
$ |
4,034 |
||
Accrued liabilities |
|
23,473 |
|
9,030 |
||
Operating lease liabilities, current portion |
|
1,075 |
|
1,021 |
||
Notes payable, at fair value - short term |
|
17,050 |
|
� |
||
Total current liabilities |
|
49,395 |
|
14,085 |
||
Notes payable, at fair value - long term |
|
� |
|
12,010 |
||
Warrant liability |
|
2,080 |
|
6,640 |
||
Long-term deferred revenue |
|
294 |
|
369 |
||
Operating lease liabilities, noncurrent |
|
2,465 |
|
3,269 |
||
Total liabilities |
|
54,234 |
|
36,373 |
||
Total stockholders' equity |
|
3,159 |
|
17,563 |
||
Total liabilities and stockholders' equity | $ |
57,393 |
$ |
53,936 |
Genasys Inc. Consolidated Statements of Operations (Unaudited - in thousands, except per share amounts) |
||||||||||||||||
Three Months Ended June 30, |
Nine Months Ended June 30, |
|||||||||||||||
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | |||||||||||||
Revenues | $ |
9,857 |
|
$ |
7,167 |
|
$ |
23,729 |
|
$ |
17,267 |
|
||||
Cost of revenues |
|
7,260 |
|
|
3,383 |
|
|
15,344 |
|
|
9,827 |
|
||||
Gross profit |
|
2,597 |
|
|
3,784 |
|
|
8,385 |
|
|
7,440 |
|
||||
|
26.3 |
% |
|
52.8 |
% |
|
35.3 |
% |
|
43.1 |
% |
|||||
Operating expenses | ||||||||||||||||
Selling, general and administrative |
|
6,422 |
|
|
6,649 |
|
|
19,904 |
|
|
19,806 |
|
||||
Research and development |
|
2,100 |
|
|
2,496 |
|
|
6,602 |
|
|
7,218 |
|
||||
Total operating expenses |
|
8,522 |
|
|
9,145 |
|
|
26,506 |
|
|
27,024 |
|
||||
Loss from operations |
|
(5,925 |
) |
|
(5,361 |
) |
|
(18,121 |
) |
|
(19,584 |
) |
||||
Other income, net |
|
(554 |
) |
|
(1,363 |
) |
|
1,496 |
|
|
(1,236 |
) |
||||
Loss before income taxes |
|
(6,479 |
) |
|
(6,724 |
) |
|
(16,625 |
) |
|
(20,820 |
) |
||||
Income tax (expense) benefit |
|
8 |
|
|
(42 |
) |
|
79 |
|
|
(476 |
) |
||||
Net loss | $ |
(6,487 |
) |
$ |
(6,682 |
) |
$ |
(16,704 |
) |
$ |
(20,344 |
) |
||||
Net loss per common share - basic and diluted | $ |
(0.14 |
) |
$ |
(0.15 |
) |
$ |
(0.37 |
) |
$ |
(0.46 |
) |
||||
Weighted average common shares outstanding - basic and diluted |
|
45,155 |
|
|
44,598 |
|
|
45,023 |
|
|
44,217 |
|
||||
Reconciliation of GAAP measures to non-GAAP measures | ||||||||||||||||
Net loss | $ |
(6,487 |
) |
$ |
(6,682 |
) |
$ |
(16,704 |
) |
$ |
(20,344 |
) |
||||
Other income, net |
|
554 |
|
|
1,363 |
|
|
(1,496 |
) |
|
1,236 |
|
||||
Income tax expense (benefit) |
|
8 |
|
|
(42 |
) |
|
79 |
|
|
(476 |
) |
||||
Depreciation and amortization |
|
685 |
|
|
733 |
|
|
2,114 |
|
|
2,193 |
|
||||
Stock based compensation |
|
459 |
|
|
299 |
|
|
1,264 |
|
|
1,269 |
|
||||
Adjusted EBITDA | $ |
(4,781 |
) |
$ |
(4,329 |
) |
$ |
(14,743 |
) |
$ |
(16,122 |
) |
View source version on businesswire.com:
Investor Relations Contacts
Brian Alger, CFA
SVP, IR and Corporate Development
[email protected]
(858) 676-0582
Source: Genasys Inc.